The life sciences industry is ever changing, being faced with major disruptions constantly. For manufacturers challenged with increasing regulations, it has become clear that the traditional approach of manual and disconnected processes is no longer feasible. Operating paper-based systems or bloated spreadsheets for business-critical tasks around labelling and artwork management (LAM) significantly slows down the review and approvals process, leading to outdated or unapproved content slipping the net and slower go-to-market times for new products.
Although initially daunting, moving towards a digitized LAM system will enable life sciences manufacturers to be better prepared to handle future industry disruption and changing regulatory demands, with major benefits such as:
• Faster speed to market for new or updated products
• Ease and speed of implementation of mass changes to labelling in response to changing regulations
• Reduced product recalls due to labelling issues
• Improved quality and compliance across the end-to-end the labelling process
• Reduced human error through the use of automation
• Meet compliance deadlines comfortably, avoiding financial penalties, regulator inspections and even sales bans
• Full product traceability, from the moment it is created to when it is printed
In this webinar, Kallik’s CEO, Gurdip Singh, and Life Sciences labelling Specialist, Bob Tilling, will guide attendees through their digital maturity journey and how to best use technology to have the right information, on the right label, at the right time. By following the Digital Maturity Curve - a best practice, step-by-step methodology- life sciences manufacturers can take gradual steps into assessing their business landscape and transitioning to digital solutions.
Sign up to the webinar now to learn how your organization can start to drive efficiency and control with automated labelling and artwork management.
Presented by
Bob Tiling,
Life Sciences Labelling Specialist
Bob has over 20 years’ experience in the life-sciences arena with a focus on helping medical device and pharmaceutical organizations overcome challenges with their labelling and artwork management. At Kallik, his expertise has enabled companies to comply with new labelling regulations in time, as well as reduce costs and improve time-to-market. Bob is passionate about transforming life sciences companies labelling and artwork processes to remove human error at label print time thus ensuring the right label is always on the right product.
Gurdip Singh,
Chief Executive Officer
Gurdip is a deeply experienced practitioner and leader in life sciences industry transformation. Before joining Kallik as CEO, he held senior life sciences industry leadership roles at CSC, then DXC Technology.
Gurdip has deep experience of driving organizational transformation in heavily-regulated industries, where he has been actively delivering change for the last decade as an advisor and practitioner.